Shire PLC. - Company & Market Research Reports

Shire is a global biotechnology company that focuses on rare diseases and other highly specialized conditions. The company's products are available in more than 100 countries across core therapeutic areas including hematology, immunology, neuroscience, lysosomal storage disorders, oncology and ophthalmics. It has offices in Dublin, Chicago and Zug, Switzerland. Shire was founded in 1986 by Harry Stratford, Dennis Stephens, Peter Moriarty, and Geoff Hall.


Ocular Hypertension: Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Ocular Hypertension: Drug Development Pipeline Study, H1 2018

  • Report
  • 61 Pages
From
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015 - Product Thumbnail Image

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015

  • Report
  • 57 Pages
From
Immunoglobulin A Nephropathy Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, Patient Size, and Epidemiology Forecast to 2025 - Product Thumbnail Image

Immunoglobulin A Nephropathy Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, Patient Size, and Epidemiology Forecast to 2025

  • Report
  • 130 Pages
From
Investigation Report on China's Celecoxib Market, 2010-2019 - Product Thumbnail Image

Investigation Report on China's Celecoxib Market, 2010-2019

  • Report
  • 20 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Report
  • 482 Pages
From
Ulcerative Colitis - Pipeline Review, H2 2017 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2017

  • Report
  • 433 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2017 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2017

  • Report
  • 409 Pages
From
Viral Conjunctivitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Viral Conjunctivitis - Pipeline Review, H1 2018

  • Report
  • 34 Pages
From
Viral Conjunctivitis - Pipeline Insight, 2018 - Product Thumbnail Image

Viral Conjunctivitis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Hemochromatosis/Iron Overload Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Hemochromatosis/Iron Overload Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 67 Pages
From
Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 85 Pages
From
Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 68 Pages
From
Secondary Hyperparathyroidism - Pipeline Review, H1 2018 - Product Thumbnail Image

Secondary Hyperparathyroidism - Pipeline Review, H1 2018

  • Report
  • 40 Pages
From
Secondary Hyperparathyroidism - Pipeline Review, H2 2017 - Product Thumbnail Image

Secondary Hyperparathyroidism - Pipeline Review, H2 2017

  • Report
  • 38 Pages
From
Secondary Hyperparathyroidism - Pipeline Insight, 2018 - Product Thumbnail Image

Secondary Hyperparathyroidism - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Hyperparathyroidism - Pipeline Insight, 2018 - Product Thumbnail Image

Hyperparathyroidism - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 68 Pages
From
Esophageal Diseases Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Esophageal Diseases Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 661 Pages
From
Gastroparesis Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Gastroparesis Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 102 Pages
From
Loading Indicator
adroll